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Abstract Regeneration and growth that occur in the adult teleost retina have 
been helpful in identifying molecular and cellular mechanisms underlying cell 
proliferation and differentiation. Here, it is reported that S-phase cell number, 
in the ciliary marginal zone (CMZ) of the adult zebrafish retina, exhibits day-
night variations with a mid-light phase peak. Oscillations persist for 24 h in 
constant darkness (DD), suggesting control by a circadian component. However, 
variations in the S-phase nuclei number were rapidly dampened and not pres-
ent during and after a second day in DD. An ADPbS treatment significantly 
enhanced S-phase activity at night to mid-light levels, as assessed by in vivo 
BrdU incorporation in a 2-h interval. Moreover, daylight increase in S-phase 
cell number was completely abolished when extracellular nucleotide levels or 
their extracellular hydrolysis by ectonucleoside triphosphate diphosphohydro-
lases (NTPDases) were significantly disrupted or when a selective antagonist of 
purinergic P2Y1 receptors was intraocularly injected before BrdU exposure. 
extracellular nucleotides and NTPDase action were also important for main-
taining nocturnal low levels of S-phase activity in the CMZ. Finally, we showed 
that mRNAs of NTPDases 1, 2 (3 isoforms), and 3 as well as of P2Y1 receptor 
are present in the neural retina of zebrafish. NTPDase mRNA expression exhib-
ited a 2-fold increment in light versus dark conditions as assessed by quantita-
tive RT-PCR, whereas P2Y1 receptor mRNA levels did not show significant 
day-night variations. This study demonstrates a key role for nucleotides, prin-
cipally ADP as a paracrine signal, as well as for NTPDases, the plasma 
membrane–bound enzymes that control extracellular nucleotide concentration, 
for inducing S-phase cell entry in the CMZ—normally associated with retinal 
growth—throughout the light-dark cycle.
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eyes in teleost fish grow throughout life, and the 
mature retina matches this growth by stretching and 
the continuous genesis of new cells (Johns and Fernald, 
1981; Stenkamp, 2007). Cell proliferation and differ-
entiation occur in a neuroepithelial zone at the inter-
face between neural retina and ciliary epithelium, 
called the ciliary marginal zone (CMZ) (Lyall, 1957; 
Reh and Fischer, 2001). Within mature retina, rod pho-
toreceptors differentiate from precursor cells within 
the outer nuclear layer (ONL) (Johns and Fernald, 
1981). In embryonic development, retinal cells clon-
ally originate from a common cell precursor. However, 
whether a unique cell precursor exists in the CMZ 
and the nature of the extrinsic and intrinsic signals 
that regulate retinogenesis are subjects of intense inves-
tigation. Light, for a photosensitive tissue such as the 
retina, might regulate normal growth and cell prolif-
eration like in other zebrafish larval tissues (Dekens 
et al., 2003). In fact, daily variations of rod precursor 
proliferation during the light-dark (LD) cycle has 
been described in a teleost fish (Chiu et al., 1995). 
Several studies in the vertebrate retina have revealed 
that a circadian clock drives many retinal functions 
(Cahill and Besharse, 1995).
extracellular nucleotides/nucleosides (eNCT/S) 
in the retina are important cues for neuron-glia com-
munication (Newman, 2006). ATP is released by exo-
cytosis in the nervous system (Burnstock, 2006) and 
via gap junction hemi-channels in the retina (Pearson 
et al., 2005). Di- and triphosphate nucleotides such as 
ATP, ADP, and UTP are extracellularly dephosphory-
lated by ectonucleoside triphosphate diphospho-
hydrolases (eNTPDases). The coordinated action of 
eNTPDases and an ecto-5′-nucleotidase dephosphor-
ylates extracellular ATP to adenosine (Hunsucker 
et al., 2005). eNCT/S act via specific purinergic or 
P receptors in the plasma membrane (Burnstock, 1978; 
2007). Studies on retinal development in the chick 
embryo suggest a role for eNCT/S in regulating pro-
genitor cell proliferation (Pearson et al., 2005; França 
et al., 2007). Interestingly, NTPDase2 and ADP par-
ticipate in eye and retina morphogenesis in Xenopus 
laevis (Massé et al., 2007).
Therefore, we investigated the role of extracellular 
ATP and its metabolites in regulating S-phase cell 
activity in the CMZ of the zebrafish retina, which we 
have found follows day-night oscillations during the 
LD cycle that persist for 24 h in constant darkness 
(DD). The number of S-phase nuclei was highest at 
the mid-light phase and mid-subjective day. S-phase 
cell number was regulated by eNCT in both light and 
darkness. mRNAs of NTPDases 1, 2, and 3 are exp-
ressed in the zebrafish retina, and their levels showed 
significant day-night variations.
MATERIALS AND METHODS 
Materials
Materials included paraformaldehyde; PBS (137 mM 
NaCl, 2.7 mM KCl, 5.7 mM phosphate, pH:7.4); 
Tween-20; MS-222; sucrose; apyrase (eC-3.6.1.5); 
hexokinase (eC-2.7.1.1); 5-bromo-2′-deoxyuridine 
(BrdU); ADPbS; 8-sulfophenyl theophylline (8-SPT) 
(Sigma, St Louis, MO); MRS2211, MRS2179, NF110, 
NF157, and ARL67156 trisodium salt (Tocris, Bristol, 
UK); mouse monoclonal anti-BrdU antibody (Roche, 
Mannheim, Germany); goat anti-mouse ALeXA 488 
antibody, random primers, dNTPs, MMLV, DTT, 
RNAseOUT, and sense and antisense primers (Invi-
trogen, Carlsbad, CA); Total RNA extraction Kit 
(RBC Biosciences, Taiwan); GoTaq-DNA polymerase, 
dNTPs-mix, DNasa-I (Promega, Madison, WI); real-
time PCR mix (Biodynamics, Buenos Aires, Argentina); 
and ultra pure agarose (GenBiotech, Buenos Aires, 
Argentina).
Animals
Adult zebrafish (Danio rerio) of about 3 cm and 1.5 g 
were maintained at 28.5 °C in a 14:10 h LD cycle 
(lights on 0700 h and off 2100 h) and fed twice a day. 
A group of zebrafish, used for night intervals, was 
raised in an inverted phase (I) 14:10 h LD cycle (lights 
on 2000h and off 1000 h) in a separate room. Other 
groups of zebrafish were transferred to DD. Animals 
were euthanized by immersion in MS-222 anesthetic 
solution (0.02% wt/vol) and then decapitated and 
enucleated, at 4 different intervals defined as Zeitgeber 
time (ZT2, ZT9, ZT16, and ZT21; ZT0 indicates lights 
on and ZT14 lights off) during the LD cycle or first, 
second, and fourth days in DD. A group of zebrafish 
from the (I) LD cycle were euthanized at ZT9 (i.e., 
mid-light for this group). The Committee on Animal 
Research at University of Buenos Aires approved pro-
tocols for animal use and care.
Intravitreal Injections
5-Bromo-2′-deoxyuridine administration. BrdU, a thymi-
dine analogue, incorporates into DNA during the 
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S-phase of the cell cycle. Anesthetized zebrafish were 
intraocularly injected with 0.5 mL of a sterile saline 
(0.65%) solution containing 20 mg/mL of BrdU, 2 h 
before euthanasia. BrdU was injected in control or 
previously treated eyes after 20 h of each treatment. 
Zebrafish in darkness were injected and euthanized 
in dim far red light.
eNCT hydrolyzing enzyme treatment. Apyrase dephos-
phorylates diphosphate and triphosphate nucleotides 
whereas hexokinase hydrolyzes ATP to phosphory-
lated D-hexose plus ADP. We injected 0.5 mL of 25 U/
mL apyrase, hexokinase, or heat-inactivated enzymes 
(boiled for 5 min) once. Zebrafish were euthanized 22 
h later to prepare eyecups. Apyrase or hexokinase 
remains active within the vitreous at least for 20 h 
(Battista et al., 2009).
Ecto-ATPase activity inhibitor treatment. ARL67156, an 
ATP analogue, selectively inhibits ecto-ATPase activ-
ity without activating purinergic receptors (Robson 
et al., 2006). We injected 100 mM ARL67156 (Westfall 
et al., 1997; Newman, 2003) via the intravitreal route in 
0.5 mL of saline solution (pIC50 = 4.62 and 5.1 in human 
blood and rat vas deferens, respectively). Zebrafish 
were euthanized 22 h later.
eNCT/S agonist and antagonist treatment. We injected 
5 mM MRS2211, 1 mM MRS2179, 10 mM 8-SPT, or 5 mM 
NF157 plus 5 mM NF110, and 22 h later zebrafish 
were euthanized (after 2 h of BrdU exposure). 
Additionally, a group of zebrafish were injected with 
25 mM ADPbS, a slightly hydrolysable ADP analogue. 
Control eyes from different zebrafish were injected 
with sterile saline.
MRS2211. P2Y13 receptor antagonist (IC50 = 1.07 mM) 
displays greater than 20-fold selectivity over P2Y1. 
Agonist relative specificity: ADP>>ATP. MRS2179: 
P2Y1 receptor antagonist (IC50 = 0.330 mM; Ki = 100 nM); 
selective over P2X1/X3/X2/X4 and P2Y2/Y4/Y6 
receptors. Agonist relative specificity: ADPbS>
ADP>>ATP (Burnstock, 2007). NF110: high-affinity 
P2X3 receptor antagonist (IC50 = 0.527 mM; Ki = 
36/82/4144 nM for ATP-activated P2X3/X1/X2, 
respectively); shows no activity on P2Y1/Y2/Y11 
receptors (IC50 >10 mM). NF157: Potent antagonist of 
P2Y11 receptors (IC50 = 0.463 mM); selective for ATP-
activated P2Y11 and P2X1 over P2Y1/Y2, P2X2/
X3/X4/X7 receptors. Agonist relative specificity: 
ATPgS>ATP (Burnstock, 2007). 8-sulfophenyl the-
ophylline (8-SPT): adenosine P1 receptors antago-
nist (Ki = 1.2 mM).
Immunocytochemistry
To prepare eyecups, the cornea, lens, and vitreous 
were removed. eyecups were fixed with 4% para-
formaldehyde for 1 h at room temperature (RT); 
incubated in 5%, 10% (30 min), and 20% sucrose (over-
night); and embedded in tissue freezing medium. We 
collected 16-mm cryosections onto gelatin-subbed slides, 
which were kept at –20 °C. Retinal sections were incu-
bated in 2 M HCl for 15 min at 37 °C and thoroughly 
washed with PBST (PBS plus 0.1% Tween-20). Then, 
sections were incubated 1 h at RT in 5% normal goat 
serum (NGS) and overnight with an antibody against 
BrdU (1:200 in 3% NGS) at 4 °C. Sections were washed 
and incubated in darkness for 2 h at RT, with a fluores-
cent antibody (1:400 in 3% NGS). Omission of antibod-
ies was performed as negative controls.
Counting of BrdU-Positive Nuclei 
eyecups were cut in the sagittal plane (nasal to 
temporal). each slide contained sections from different 
portions of the eyecup. We identified BrdU-positive 
nuclei focusing through the section in both CMZ 
under microscopic observation. We counted all BrdU-
positive nuclei in 10 to 12 nonadjacent sections from 
each eye. Nuclei in the nonlaminated retina at both 
ends were considered CMZ nuclei. Differences among 
groups were analyzed using 1-way ANOVA, followed 
by Tukey-Kramer multiple comparison test or Student 
t test.
Microscopy
Counting was performed with an epifluorescence 
microscope (Olympus BX50, Japan; objective 40X-NA: 
0.75). Confocal images were captured with an FV1000 
Fluoview spectral microscope (Olympus; objective 
SAPO-60X oil-NA: 1.35). Two-dimensional confocal 
and differential interference contrast (DIC) images were 
obtained from Z-stacks by using Fluoview software.
Reverse Transcription (RT)  
and Polymerase Chain Reaction (PCR)
Groups of 5 zebrafish were euthanized at ZT7–9 
(mid-light phase) in bright light and ZT14–16 (1:30 h 
of darkness) in dim far red light. Ten neural retinas 
were homogenized in a buffer of a RNA purification kit 
and considered a sample. Three to 4 sample replicates 
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were examined for each interval. RNA was quanti-
fied and DNAse-I treated (30 min, 25 °C). cDNA was 
reverse transcribed from RNA with random primers 
and quantified with a NanoDrop 3300 spectropho-
tometer (Thermo Fisher Scientific, Waltham, MA). 
either 1 or 2 mg of cDNA was used for real-time 
quantitative PCR (qPCR) (RotorGene 6000; Quiagen, 
Valencia, CA). Specific primers were selected using 
Beacon Designer Software (Premier Biosoft Inter-
national, Palo Alto, CA) from zebrafish genome rep-
orted in ensembl database (Table 1). Products of 
standard or qPCR were checked by electrophoresis 
in 2% agarose gels. No-RT controls, in which the 
MMLV–reverse transcriptase was omitted, were amp-
lified by qPCR with every primer pair. No-RT sam-
ples showed background fluorescence levels. No-RT 
or cDNA-containing samples were run in triplicates. 
b-Actin (internal reference gene) expression showed 
no significant variations among intervals and was 
amplified in parallel with each gene of interest (target 
genes). Slopes from qPCR kinetic curves obtained as 
the logarithm of relative fluorescence after n cycles 
(Rn) plotted against the number of cycles (n) were 
calculated for each sample for b-actin and target genes. 
equation 1 describes the linear range in the exponen-
tial phase of the kinetic curve:
 lg Rn = lg (1 + e) n + lg Ro (1)
where Ro is the initial fluorescence amount and e is 
the PCR efficiency. Within the linear range, we defi-
ned a trendline of 4 to 5 data points, with the highest 
possible slope and correlation coefficient, and calcu-
lated the efficiency for each reaction (e = 10slope – 1). 
Averaged amplification efficiencies for each sample 
were 1 ± 0.02 (mean ± SD) for reference or interest 
genes (Schefe et al., 2006). Samples with efficiencies 
out of this interval were considered outliers and not 
included in data analysis. 
Quantitative PCR  
Data Analysis 
Analysis was performed 
throughout the 2–DDCT method 
as described by Livak and 
Schmittgen (2001). An arbi-
trary fluorescence threshold 
of 0.06 was used to obtain CT 
values from each curve. We 
chose cDNA samples from 
mid-light intervals (ZT7–9) 
as the interest sample and beginning of darkness 
(ZT14–16) as the calibrator sample. Both CT values 
were previously normalized with b-actin. We 
obtained a ratio that indicates fold change of mRNA 
levels of each target gene at ZT7–9 over ZT14–16. For 
the calibrator sample, 2–DDCT value equals 1. Relative 
values from each pool of 10 retinas are reported. 
Standard deviations (SD) from triplicates were prop-
agated by using standard methods and confidence 
intervals were calculated as: 2–(DDCT ± propagated SD) (Livak 
and Schmittgen, 2001).
RESULTS
S-Phase Nuclei Number  
in the CMZ Shows Day-Night Variations  
That Persist for 24 h in DD
We counted BrdU-positive nuclei (S-phase nuclei) 
within the following 2-h intervals: ZT0–2 and ZT7–9 
in light, ZT14–16 and ZT19–21 in darkness (Figure 1A). 
Despite the scant number of BrdU-positive nuclei per 
CMZ/section, this parameter showed daily variations 
with a peak at ZT7–9, that is, after 7 to 9 h of light 
(4.78 ± 0.98 nuclei, n = 8 zebrafish). After 2 h of dark-
ness (ZT14–16), S-phase cell number decreased to a 
minimum (1.49 ± 0.30 nuclei, n = 5 zebrafish), which 
was significantly different from BrdU-positive nuclei 
after 7 h of darkness (ZT19–21: 2.80 ± 0.56 nuclei, n = 
8 zebrafish). At dawn, ZT0–2, BrdU-positive nuclei 
were (2.34 ± 0.78, n = 7 zebrafish) not different from 
night values. The ratio of S-phase nuclei at the mid-
light peak to the trough at night was 3.2 to 1. Upon 
transfer to DD, S-phase cell number showed significant 
variations among intervals for 24 h (ZT0–2: 2.72 ± 
0.44; ZT7–9, 4.83 ± 0.43; ZT14–16, 1.05 ± 0.07; ZT19–21, 
1.80 ± 0.32; n = 4 zebrafish per interval; Figure 1B) with 
a maximum to minimum ratio of 4.6 to 1. Subjective 
Table 1. Specific primers for each target gene and reference gene (b-actin).
Gene Sense Antisense
NTPDase1 TCACAGACACAGCGAAACCC GAATGTGCAACGGAGGTAAGC
NTPDase2 mq GAGCAGCAGCACGTAGCC GACCTCAGCCGACTCTTTGG
NTPDase2 mg CTTACGCCTCTTTGGACACG AGTCAGATGGATAGCAGGGATG
NTPDase2 mv TGATGGAGTCTTTCAGCCCAAC AGCAGCGTCCTCTAAATGAGC
NTPDase3 GGCTGGATCACTGTCAACTACC CCCAAATCCAATGACCCAACTG
P2Y1 receptor TATGGACAATGCTCCGCTTAGG CGCTCTCATGTTCAGGTTCTTC
β-actin TCCCAAAGCCAACAGAGAGAAG GTCACACCATCACCAGAGTCC
Primers were selected by using exon sequences from zebrafish genome (ensembl database). Selected 
primer pairs did not hybridize with other NTPDase enzyme or isoform (mq, mg, mv).
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day values were significantly higher than values at 
subjective night. Confocal images with a representa-
tive S-phase nuclei number at ZT7–9 and ZT14–16 in 
LD and 1 day in DD are shown in Supplementary 
Figure S1A-D and e-H, respectively. In contrast, 
BrdU-positive nuclei number during the second day 
in DD (ZT0–2: 1.30 ± 0.29; ZT7–9: 1.60 ± 0.43; ZT14–
16: 1.37 ± 0.09; ZT19–21: 1.26 ± 0.47, n = 4 zebrafish 
per interval; Figure 1C) or the fourth day in DD 
(ZT0–2: 2.65 ± 0.57; ZT7–9: 2.03 ± 0.30; ZT14–16: 2.97 ± 
0.90; ZT19–21: 3.00 ± 0.57, n = 6 zebrafish per interval; 
Figure 1D) did not show significant variations among 
intervals. During subjective days 2 and 4, BrdU-
positive nuclei failed to increase to the LD mid-light 
peak (Figure 1A) versus DD through all ZT intervals 
(Figure 1C and D; p < 0.001, Tukey-Kramer after 
ANOVA). Moreover, during the second day in DD, 
values were not statistically different from the night 
minimum in LD (Figure 1A vs. 1C). In contrast, 
BrdU-positive nuclei number during day 4 in DD 
was significantly higher at ZT14–16 and 
ZT19–21 (Figure 1D) than at ZT14–16 in 
LD (Figure 1A) (p < 0.05, Tukey-Kramer 
after ANOVA). Data from day 4 in 
DD intervals (except for ZT7–9) were 
significantly higher than those observed 
during the second day in DD (p < 0.05, 
p < 0.01; Figure 1C vs. 1D). 
Supplementary Figure S2 depicts 
S-phase nuclei number in the CMZ of 
2 groups of zebrafish injected with BrdU 
at ZT7 and euthanized at ZT9 (mid-light 
for both groups of fish). One of the 
groups was kept in a different room in a 
12-h shifted phase relative to the other. 
BrdU-positive nuclei number in both 
groups did not show significant differ-
ences (ZT7–9: 4.78 ± 0.98, n = 8; ZT7–9(I): 
4.72 ± 0.15 n = 3 zebrafish).
Effect of eNCT Hydrolyzing  
Enzymes and an EctoATPase  
Selective Blocker on S-Phase Cell 
Activity During the LD Cycle
Figure 2 shows the effect of apyrase 
or hexokinase activity on S-phase nuclei 
number at different intervals. Apyrase 
treatment significantly decreased BrdU-
positive nuclei number at the CMZ at both 
night and daylight as compared to heat-inactivated 
apyrase-treated retinas (ZT7–9: 3.99 ± 0.26, n = 3; 
ZT14–16: 1.69 ± 0.30, n = 3) and saline controls (ZT7–
9: 4.20 ± 0.26, n = 3; ZT14–16: 1.67 ± 0.10, n = 3). 
Control data were not significantly different (ZT7–9: 
p = 0.3788 and ZT14–16: p = 0.9864), and they were 
pooled in Figures 2A and B. At ZT7–9, S-phase cell 
number in apyrase-treated retinas diminished below 
control night levels (apyrase ZT7–9: 0.61 ± 0.20, n = 4 
[Figure 2A] vs. control ZT14–16: 1.68 ± 0.20, n = 6 
[Figure 2B] and ZT19–21: 2.19 ± 0.34, n = 3 [Figure 
2C]; p < 0.001). The low number of BrdU-positive 
nuclei at night was further decreased to either 1 or 
zero in the majority of the quantified sections (ZT14–
16: apyrase 0.60 ± 0.15, n = 4 vs. control 1.68 ± 0.20, 
n = 6 [Figure 2B]; ZT19–21: apyrase 0.39 ± 0.12, n = 4 
vs. control 2.19 ± 0.34, n = 3 [Figure 2C]). In contrast, 
intravitreal activity of hexokinase showed no signifi-
cant effect on S-phase nuclei number either in light or 
dark conditions as compared to the heat-inactivated 
Figure 1. Number of BrdU-positive nuclei plotted as a function of time of day 
(ZT) in a 14:10 h LD cycle (A) or during the first (B), second (C), or fourth (D) day 
in DD. Zebrafish were handled either in light or under far red illumination. Values 
are BrdU-positive cell number per ciliary marginal zone (CMZ) per retinal section 
and are mean ± SD (n = 4–8 zebrafish per ZT interval; ZT0 is lights on and ZT14 
lights off). Brackets indicate significant differences between intervals. ***p < 0.001; 
*p < 0.05, Tukey-Kramer multiple comparison test after 1-way ANOVA.
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hexokinase-treated retinas (ZT7–9: hexokinase 4.13 ± 
0.22 and control 4.21 ± 0.58, n = 4; ZT14–16: hexoki-
nase 1.56 ± 0.27, n = 4 and control 1.53 ± 0.36, n = 5) 
(Figure 2D, e). Furthermore, when ARL67156—
known to inhibit NTPDase activity at the concentra-
tion tested—was injected within the vitreous (Figure 3 
A-C), it significantly decreased BrdU-positive nuclei 
number at mid-light to levels below those normally 
observed at night (ARL67156: ZT7–9, 0.91 ± 0.22, n = 
4 [Figure 3A] vs. control: ZT14–16, 1.68 ± 0.20, n = 6 
[Figure 3B] and ZT19–21, 2.12 ± 0.28, n = 5 [Figure 
3C]; p < 0.001). ARL67156 treatment also decreased 
BrdU-positive nuclei number at night (ARL67156: 
ZT14–16, 0.29 ± 0.05, n = 4 [Figure 3B]; ZT19–21, 0.32 
± 0.11, n = 4 [Figure 3C]). Supplementary Figure S1 
shows confocal images with a representative number 
of S-phase cells in the CMZ at ZT7–9 in 
abs ence (I, J) or presence (K, L) of active 
apyrase and without (M, N) or with 
ARL67156 treatment (O, P). 
Specific eNCT Regulate  
S-Phase Cell Activity  
in the CMZ During the LD Cycle 
Figure 3A-C depicts data showing 
that MRS2179—a selective antagonist of 
ADP-activated P2Y1 metabotropic 
receptors—significantly reduced BrdU-
positive nuclei number at mid-light, to 
levels below control values recorded at 
night (MRS2179: ZT7–9, 0.76 ± 0.34, n = 
4 [Figure 3A] vs. control: ZT14–16, 1.68 ± 
0.20, n = 6 [Figure 3B] and ZT19–21, 2.12 
± 0.28, n = 5 [Fig 3C]; p < 0.001). MRS2179, 
like apyrase or ARL67156 treatments, 
significantly decreased BrdU-positive 
nuclei counts at night to less than a 
dividing nucleus in a 2-h window per 
retinal section (MRS2179: ZT14–16, 0.51 
± 0.17 [Figure 3B] and ZT19–21, 0.60 ± 
0.39 [Figure 3C]; n = 4 zebrafish per 
group). In contrast, P2 receptor antago-
nists such as MRS2211, which blocks 
ADP action on P2Y13 receptors, showed 
no significant effect (MRS2211: ZT7–9, 
3.95 ± 0.21 [Figure 3D]; ZT14–16, 1.97 ± 
0.10 [Figure 3e], n = 4 zebrafish per 
group). Antagonists for ionotropic 
P2X1/2/3 and metabotropic P2Y11 
receptors also failed in demonstrating 
an ATP-induced effect on S-phase cell activity 
(NF110/157: ZT7–9, 3.97 ± 0.07 [Figure 3e]; ZT14–16, 
1.73 ± 0.13 [Figure 3D]; n = 4 zebrafish per group). 
Likewise, 8-SPT an antagonist for adenosine-acti-
vated P1 receptors did not alter BrdU-positive nuclei 
number at any interval examined (8-SPT: ZT7–9, 3.87 
± 0.64 [Figure 3e]; ZT14–16, 1.94 ± 0.32 [Figure 3D]; 
n = 4 zebrafish per group). For MRS2211, NF110/157 
and 8-SPT control values were ZT7–9, 4.18 ± 0.55; 
ZT14–16, 1.68 ± 0.25, n = 4 zebrafish per group. 
Consistent with this, 1 intravitreal injection of 
ADPbS, an agonist for P2Y1 receptors, caused a sig-
nificant increase of the number of BrdU-positive 
nuclei in the CMZ at night (control: ZT14–16, 1.63 ± 
0.22, n = 4 [Figure 3F]). S-phase nuclei number in the 
presence of ADPbS at ZT14–16 was statistically 
Figure 2. Apyrase or hexokinase activity effect on BrdU-positive nuclei number 
analyzed at daily intervals during a 14:10-h LD cycle. Eyes underwent intravitreal 
injection of saline, apyrase, or heat-inactivated apyrase (A-C) or hexokinase or 
heat-inactivated hexokinase (D, E). Twenty hours later, they were injected with a 
solution containing BrdU (20 mg/mL). Zebrafish were euthanized 2 h later at the end 
of the indicated ZT interval (ZT0 is lights on and ZT14 lights off). Values represent 
the number of BrdU-positive cells per ciliary marginal zone (CMZ)/retinal section 
and are mean ± SD. Controls: ZT7–9 and ZT14–16 saline plus heat-inactivated apy-
rase (n = 6 zebrafish per ZT); ZT19–21 heat-inactivated apyrase (n = 3 zebrafish); 
ZT7–9 and ZT14–16 heat-inactivated hexokinase (n = 4–5 zebrafish). Apyrase- or 
hexokinase-treated retinas: n = 4 zebrafish per ZT interval. Brackets indicate sig-
nificant differences between treatments. ***p < 0.001 by Student t test.
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n = 7 [Figure 3A]; p = 0.1996). 
Supplemen-tary Figure S1 depicts 
2-dimensional confocal images 
with a representative S-phase nuclei 
number in the CMZ at ZT14–16 in 
absence (Q, R) or presence (S, T) of 
ADPbS.
NTPDase mRNA Levels Show 
Day-Night Variations  
in the Zebrafish Retina
RT-PCR experiments demon-
strated mRNA exp ression of 
NTPDases 1, 2, and 3 as well as of 
ADP-activated P2Y1 metabotro pic 
receptor in the zebrafish neural ret-
ina (Figure 4C). One band was 
observed with each primer pair, and 
amplicon lengths matched expected 
molecular weig hts. Furthermore, 
mq, mv, and mg isoforms for 
NTPDase2 previously des cribed in 
other tissues were identified. To 
reliably detect mg isoform, we used 
2 mg of cDNA, whereas 1 mg was 
sufficient to identify mv and mq iso-
forms or NTPDases 1 and 3. 
NTPDase mRNA levels during the 
LD cycle sho wed a higher expres-
sion in mid-light phase (ZT7–9) 
than at the beginning of night, after 
1:30 h of darkness (ZT14–16) (Figure 
4A, B). expression level of NTPDase 
mRNAs between intervals was on 
average about 2- to 3-fold. In con-
trast, P2Y1 receptor mRNA levels 
did not show apparent day-night 
variations.
DISCUSSION
Here we report daily vari ations 
in S-phase progenitor cell activity 
in the CMZ of the adult zebrafish 
retina, with highest values at the 
mid-light phase. The observed day-night oscilla-
tions persist for 24 h in free-running conditions. 
S-phase activity in the CMZ is strongly regulated by 
Figure 3. P receptor agonist and antagonists and an ectoATPase activity inhibitor effect on 
BrdU-positive nuclei number at different intervals during a 14:10-h LD cycle. Eyes under-
went intravitreal injection with saline, ARL67156, or MRS2179 (A-C); saline, 8-SPT, 
MRS2211, or NF110/157 (D, E); or saline or ADPbS (F). Twenty hours later, they were 
injected with a solution containing BrdU (20 mg/mL). After 2 h, zebrafish were euthanized 
at the end of the indicated ZT interval (ZT0 is lights on and ZT14 lights off). Values repre-
sent BrdU-positive cell number per ciliary marginal zone (CMZ)/retinal section and are 
mean ± SD. (A) ZT7–9: n = 4–7 zebrafish. (B) ZT14–16: n = 4–6 zebrafish. (C) ZT19–21: n = 4–5 
zebrafish. (D) ZT7–9 and (E) ZT14–16: n = 4 zebrafish per group. (F) ZT14–16: n = 4–5 zebraf-
ish. Brackets indicate significant differences between treatments. ***p < 0.001, as assessed 
by Tukey-Kramer multiple comparison test after 1-way ANOVA or Student t test.
indistinguishable from mid-light values in absence 
of exogenous nucleotides (ADPbS: ZT14–16, 3.62 ± 
0.32, n = 5 [Figure 3F] vs. control: ZT7–9, 3.95 ± 0.45 
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eNCT levels and hence by the activity of 
plasma membrane-bound NTPDases. 
NTPDase mRNA expression is differen-
tially regulated during the LD cycle.
S-Phase Cell Activity  
in the CMZ Shows Day-Night  
Oscillations in LD That Persist  
for One Day in Constant Darkness 
It has been reported that the prolifera-
tive activity of rod precursors in the ONL 
of a teleost fish retina (Haplochromis bur-
toni) exhibits circadian driven variations 
with a peak at night (Chiu et al., 1995). 
Here we showed day-night variations of 
S-phase nuclei number during a regular 
LD cycle that are at least 3 times higher 
at daylight than in darkness. A further 
control was made because, as aforemen-
tioned, zebrafish for light intervals were 
maintained in a separate room with an 
inverted (I) LD phase from zebrafish 
for night intervals. Results indicated that 
BrdU-positive nuclei number peak is res-
ynchronized by light to a 12-h shifted LD 
cycle (as shown in Supplemental Figure 
S2), and the observed differences between 
groups at daylight or night intervals are 
not due to any uncontrolled environmental 
variable.
Rod precursors in the ONL (Johns and 
Fernald, 1981) or proliferative cells in the 
INL (Julian et al., 1998; Battista et al., 
2009) were virtually unlabeled under our 
experimental conditions (2 h of BrdU 
exposure); therefore, we could not assess 
day-night variations in these cell popula-
tions. S-phase activity in the CMZ, which 
involves a different neurogenic cell pop-
ulation, seems to be coincident with a 
higher behavioral activity (Cahill et al., 
1998) and visual sensitivity at daylight 
(Li and Dowling, 1998). Mitotic division 
in vertebrates occurs several hours after 
S phase—in our experiments, at the end 
of the light phase or beginning of the dark 
phase. Therefore, BrdU in our experi mental 
conditions labeled S-phase nuclei that 
did not reach the mitotic phase (Matsuo 
et al., 2003). Oscillations of S-phase cell 
Figure 4. NTPDases and P2Y1 receptor expression in the zebrafish retina identi-
fied by real time quantitative RT-PCR (qPCR). RNA was purified from 3–4 pools 
(samples A–D) of 10 retinas each obtained at the mid-light phase (ZT7–9) or begin-
ning of the dark phase (ZT14–16) of a 14:10-h LD cycle (ZT0 is lights on and ZT14 
lights off). Total RNA was treated with DNAse-I, retro-transcribed to cDNA, and 
amplified by qPCR. One microgram of cDNA, except for NTPDase2 mg isoform 
(2 mg), was used as template for qPCR reactions, with primers for b-actin (refer-
ence) or specific primers for each target gene. Fold change is the media from trip-
licate values (for each reaction) normalized to an internal reference and a calibrator 
sample (ZT14–16) that was calculated by the 2–DDCT method. Propagated errors were 
estimated from triplicate SD by using standard methods. Error ranges (brackets) 
were calculated as 2–(DDCT ± propagated SD). Amplified cDNA products were separated by 
electrophoresis in a 2% agarose gel (C). NTPDase2 isoforms: mq, mg, mv.
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activity persisted 24 h in DD, suggesting that they 
are driven at least in part by a circadian pacemaker 
(Cahill, 2002; Dekens et al., 2003). Nonetheless, this 
putative rhythm rapidly dampened and disappeared 
from the second day on in DD. BrdU-positive nuclei 
number throughout day 2 in DD was low. In contrast, 
during day 4 in DD, S-phase cell activity showed 
a global nonoscillatory increase, suggesting a light-
independent cell cycle regulation to sustain cell pro-
liferation and hence retinal growth. Light does not 
regulate cell cycle entry instantaneously, because 
S-phase cell activity showed similar levels the first 2 h 
of light (ZT0–2) or in darkness (ZT19–21). Together, 
these results might indicate that S-phase nuclei entry 
in the CMZ is driven by a weak circadian oscillator 
that maintains DD cyclic activity for 1 day. Results 
also suggest that S-phase cell activity is partially light-
driven, because LD cycle absence causes a delayed 
suppression of cyclic oscillations on day 2. A combi-
nation of a clock-driven and a delayed light-driven 
extracellular diffusible signal and/or retinal cell activ-
ity, probably including photoreceptor or another kind 
of photosensitive cells (Cheng et al., 2009), might be 
responsible for increasing daylight S-phase activity 
in the CMZ.
Apyrase and ARL67156 Exert a  
Similar Effect on Daily Variations  
of S-Phase Cell Activity
Apyrase hydrolyses triphosphate and diphosphate 
nucleotides and hence terminates their action on P2 
receptors. The action of apyrase by producing AMP 
indirectly favors adenosine formation. However, 
the lack of effect of 8-SPT suggests that endogenous 
extracellular adenosine does not regulate S-phase 
nuclei number in the CMZ. Therefore, the inhibitory 
effect of apyrase on S-phase activity in the CMZ, in 
either the light or dark phase, might result from hin-
dering nucleotide action on P2 receptors. In contrast, 
hexokinase treatment, which hydrolyzes extracellular 
ATP, did not affect S-phase nuclei number. This might 
indicate that ATP is not essential for controlling S-phase 
activity in the CMZ. Another possible candidate is 
ADP because it binds to specific P receptors—unlike 
AMP—and apyrase quickly hydrolyzes it. Hexokinase 
activity may produce ADP; however, no effect of 
hexokinase was observed in either light or darkness. 
ADP produced by hexokinase activity at daytime 
could be redundant with extracellular ADP produced 
by other enzymatic reactions. Our data suggest that 
at night, there is less extracellular ADP; nonetheless, 
hexokinase was ineffective in producing enough ADP 
to exert a significant effect on S-phase cell activity. 
This might be due to a very low extracellular ATP 
concentration at night. Alternatively, ADP produced 
within the vitreous by hexokinase could be rapidly 
hydrolyzed by endogenous ectoATPase activity 
(Battista et al, 2009).
Like the apyrase effect, ARL67156 significantly 
diminished S-phase nuclei number in the CMZ by 
inhibiting extracellular hydrolysis of nucleotides. 
Therefore, these results also suggest that ATP pres-
ence by itself in the extracellular milieu is not suffi-
cient to regulate S-phase entry. Presence of ectoATPase 
activity mainly driven by NTPDases is crucial for 
hydrolysis of eNCT and key for S-phase induction in 
the CMZ at daylight and night.
P2Y1 Receptors Mediate  
Extracellular Nucleotide Effect  
on S-Phase Cell Activity in the CMZ
A treatment with ADPbS (25 mM) led to significant 
increases in BrdU-positive cell number at nighttime. 
An elevated level of this ADP analogue for 20 h was 
a signal sufficient to increase S-phase cell number at 
night to mid-light values. There is common agree-
ment that P2Y1 receptors have a greater selectivity 
for ADP than ATP (Burnstock, 2007). In concordance 
with ADPbS results, a selective antagonist for P2Y1 
receptors MRS2179 significantly inhibited S-phase 
cell number mid-light increase. In contrast, antago-
nists selective for other ADP-activated (P2Y13) or 
ATP-activated receptors (P2X1/2/3 and P2Y11) were 
ineffective. These results suggest that the enhanced 
daylight S-phase cell number is principally mediated 
by ADP action on P2Y1 metabotropic receptors. Further 
evidence supporting this finding indicated that ADP 
is a key signal for injury-induced cell proliferation 
in the zebrafish retina (Battista et al., 2009). Moreover, 
we have also demonstrated—for the first time—that 
P2Y1 receptor mRNA is expressed in the zebrafish 
retina.
RNA Messengers for Different  
Plasma Membrane-Bound NTPDases  
Are Expressed in the Zebrafish Retina  
and Exhibit Daily Variations 
We have previously found by immunocytochemis-
try that NTPDases 1 and 2 are differentially localized 
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in mature layers as well as in the CMZ of the zebraf-
ish retina (Ricatti et al., 2009). We show here that 
NTPDase1, NTPDase3, and 3 isoforms of NTPDase2 
mRNAs previously described in the brain (Rico et al., 
2006; Appelbaum et al., 2007) are also expressed in the 
zebrafish neural retina. NTPDases are the main regu-
lating system of eNCT concentration (Zimmermann, 
2006). NTPDase1 hydrolyzes triphosphate and dip-
hosphate nucleotides with an activity ratio of 1 to 1. 
NTPDase2, in contrast, hydrolyzes principally ATP 
accumulating extracellular ADP, whereas NTPDase3 
exhibits an intermediate activity (Kukulski et al., 2005). 
In this report, we described day-night variations of 
mRNA levels for all NTPDases examined, except for 
the mg isoform, which only showed a significant 
change in 2 of 3 samples and seems to be the less 
abundantly expressed because, as mentioned before, 
we had to use twice the amount of cDNA to detect it. 
NTPDase gene expression at mid-light doubles in 
average the expression observed after a short time 
in darkness. Presumably, NTPDase activity might be 
higher at daylight than at night consistent with a tighter 
regulation of extracellular nucleotide levels. 
Different Levels of eNCT as Well  
as NTPDase Activity Might Be  
Critical to Drive CMZ S-Phase  
Cell Activity During the LD Cycle
A recent report has described that larval zebrafish 
electroretinographic activity is virtually null at night 
and is under circadian control (emran et al., 2010). 
The authors suggest that metabolic activity is signifi-
cantly diminished at night to conserve energy. In the 
adult zebrafish, a decreased retinal activity at night has 
also been reported (Li and Dowling, 1998). Presum-
ably, less activity and lowest metabolism might imply a 
reduced content of extracellular ATP (which depends 
on intracellular ATP concentration). This fact, in addi-
tion to a lower NTPDase activity, might contribute to 
low levels of extracellular ADP at night. Alternatively, 
although we did not detect day-night variations of 
P2Y1 receptor mRNA levels, a decreased response 
to eNCT at night cannot be ruled out. Therefore, 
the assumed highest levels of eNCT as well as an 
increased NTPDase mRNA expression, which might 
be under circadian control, could induce S-phase cell 
entry in the CMZ (Martins and Pearson, 2008) at day-
light or mid-subjective day for 24 h in DD. ARL67156, 
apyrase, hexokinase, and P receptor antagonist treat-
ments indicated that the BrdU-positive nuclei increase 
chiefly depends on activation of P2Y1 receptors by 
ADP as well as NTPDase extracellular activity. The 
low number of S-phase nuclei in the CMZ at night 
is also regulated by extracellular ADP—probably at 
much lower concentrations—because exogenous 
ADPbS was able to increase S-phase activity to day-
light levels. When eNCT were scavenged or NTPDase 
activity inhibited, S-phase entry in the CMZ decreased 
to almost null values. It is tempting to suggest that 
the very few remaining proliferating cells might be 
stem cells, whose cell cycle regulation is independent 
of eNCT/S.
We have demonstrated that NTPDase mRNA 
expression levels show day-night variations. These 
might be driven by a weak endogenous oscillator and/
or the photic stimulus to regulate eNCT day-night 
concentration and hence precursor cell S-phase entry 
in the CMZ. It remains to be shown, however, if light, 
a circadian mechanism, or both are indeed capable 
of regulating eNCT concentration or ATP release by 
retinal cells.
ACKNOWLEDGMENTS
We thank Drs. Adriana De Siervi and Luis Gonzalez 
Flecha for technical assistance and Drs. Pablo J. 
Schwarzbaum and Daniel P. Cardinali for reading and 
comments on the manuscript. Grant sponsors: Agencia 
Nacional de Promoción Científica y Tecnológica 
(ANPCyT-BID1728/04-PICT2004-Nº25422); Consejo 
Nacional de Investigaciones Científicas y Técnicas 
(CONICeT PIP2004-Nº6012). Argentina. 
NOTE
Supplementary online material for this article is 
available on the Journal of Biological Rhythms website: 
http://jbr.sagepub.com/supplemental. 
REFERENCES
Appelbaum L, Skariah G, Mourrain P, and Mignot e (2007) 
Comparative expression of p2x receptors and ecto-
nucleoside triphosphate diphosphohydrolase 3 in hypo-
cretin and sensory neurons in zebrafish. Brain Res 1174: 
66-75.
Battista AG, Ricatti MJ, Pafundo De, Gautier MA, and 
Faillace MP (2009) extracellular ADP regulates lesion-
induced in vivo cell proliferation and death in the 
zebrafish retina. J Neurochem 111:600-613.
Ricatti et al. / S-PHASe CeLL ACTIVITY IN ZeBRAFISH ReTINA  117 
Burnstock G (1978) A basis for distinguishing two types of 
purinergic receptors. In Cell Membrane Receptors for Drugs 
and Hormones: A Multidisciplinary Approach, Straub RW 
and Bolis L, eds, pp 107-118. New York: Raven Press.
Burnstock G (2006) Historical review: ATP as a neurotrans-
mitter. Trends Pharmacol Sci 27:166-176.
Burnstock G (2007) Physiology and pathophysiology of 
purinergic neurotransmission. Physiol Rev 87:659-797.
Cahill GM (2002) Clock mechanisms in zebrafish. Cell Tissue 
Res 309:27-34.
Cahill GM and Besharse JC (1995) Circadian rhythmicity in 
vertebrate retinas: regulation by a photoreceptor oscilla-
tor. Prog Retin eye Res 14:267-291.
Cahill GM, Hurd MW, and Batchelor MM (1998) Circadian 
rhythmicity in the locomotor activity of larval zebrafish. 
Neuroreport 9:3445-3449.
Cheng N, Tsunenari T, and Yau KW (2009) Intrinsic light 
response of retinal horizontal cells of teleosts. Nature 
460:899-903.
Chiu JF, Mack AF, and Fernald RD (1995) Daily rhythm of cell 
proliferation in the teleost retina. Brain Res 673:119-125.
Dekens MP, Santoriello C, Vallone D, Grassi G, Whitmore D, 
and Foulkes NS (2003) Light regulates the cell cycle in 
zebrafish. Curr Biol 13:2051-2057.
emran F, Rihel J, Adolph AR, and Dowling Je (2010) 
Zebrafish larvae lose vision at night. Proc Natl Acad Sci 
USA 107:6034-6039.
França GR, Freitas RC, and Ventura AL (2007) ATP-induced 
proliferation of developing retinal cells: regulation by 
factors released from postmitotic cells in culture. Int J Dev 
Neurosci 25:283-291.
Hunsucker SA, Mitchell BS, and Spychala J (2005) The 
5’-nucleotidases as regulators of nucleotide and drug 
metabolism. Pharmacol Ther 107:1-30.
Johns PR and Fernald RD (1981) Genesis of rods in teleost 
fish retina. Nature 293:141-142.
Julian D, ennis K, and Korenbrot JI (1998) Birth and fate of 
proliferative cells in the inner nuclear layer of the mature 
fish retina. J Comp Neurol 394:271-282.
Kukulski F, Levesque SA, Lavoie eG, Lecka J, Bigonnesse F, 
Knowles AF, Robson SC, Kirley TL, and Sevigny J (2005) 
Comparative hydrolysis of P2 receptor agonists by 
NTPDases 1, 2, 3 and 8. Purinergic Signal 1:193-204.
Li L and Dowling Je (1998) Zebrafish visual sensitivity is 
regulated by a circadian clock. Vis Neurosci 15:851-857.
Livak KJ and Schmittgen TD (2001) Analysis of relative 
gene expression data using real-time quantitative PCR 
and the 2-DDCT method. Methods 25:402-408.
Lyall A (1957) The growth of the trout retina. Q J Microsc 
Sci 98:101-110.
Martins RAP and Pearson RA (2008) Control of cell prolif-
eration by neurotransmitters in the developing verte-
brate retina. Brain Res 1192:37-60.
Massé K, Bhamra S, eason R, Dale N, and Jones eA (2007) 
Purine-mediated signaling triggers eye development. 
Nature 449:1058-1062.
Matsuo T, Yamaguchi S, Mitsui S, emi A, Shimoda F, and 
Okamura H (2003) Control mechanism of the circadian 
clock for timing of cell division in vivo. Science 302: 
255-259. 
Newman eA (2003) Glial cell inhibition of neurons by 
release of ATP. J Neurosci 23:1659-1666.
Newman eA (2006) A purinergic dialogue between glia 
and neurons in the retina. Novartis Found Symp 276: 
193-202.
Pearson RA, Dale N, Llaudet e, and Mobbs P (2005) ATP 
released via gap junction hemichannels from the pigment 
epithelium regulates neural retinal progenitor prolifera-
tion. Neuron 46:731-744.
Reh TA and Fischer AJ (2001) Stem cells in the vertebrate 
retina. Brain Behav evol 58:296-305.
Ricatti MJ, Alfie LD, Lavoie eG, Sevigny J, Schwarzbaum PJ, 
and Faillace MP (2009) Immunocytochemical localiza-
tion of NTPDases1 and 2 in the neural retina of mouse 
and zebrafish. Synapse 63:291-307.
Rico eP, Rosemberg DB, Senger MR, Arizi M, Bernardi GF, 
Dias RD, Bogo MR, and Bonan CD (2006) Methanol 
alters ecto-nucleotidases and acetylcholinesterase in 
zebrafish brain. Neurotoxicol Teratol 28:489-496.
Robson SC, Sévigny J, and Zimmermann H (2006) The 
e-NTPDase family of ectonucleotidases: structure func-
tion relationships and pathophysiological significance. 
Purinergic Signal 2:409-430. 
Schefe JH, Lehmann Ke, Buschmann IR, Unger T, and 
Funke-Kaiser H (2006) Quantitative real-time RT-PCR 
data analysis: current concepts and the novel “gene 
exp ression’s CT difference” formula. J Mol Med 84: 
901-910.
Stenkamp DL (2007) Neurogenesis in the fish retina. Int 
Rev Cytol 259:173-224.
Westfall TD, Kennedy C, and Sneddon P (1997) The ecto-
ATPase inhibitor ARL 67156 enhances parasympathetic 
neurotransmission in the guinea-pig urinary bladder. 
eur J Pharmacol 329:169-173.
Zimmermann H (2006) ectonucleotidases in the nervous 
system. Novartis Found Symp 276:113-128.
